drugset / Trial / NCT03596723
KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is designed to assess how KPI-121 1% compares to prednisolone acetate in reducing inflammation after cataract surgery in young children. Approximately half the participants will receive KPI-121 1% eye drops and the other half will receive prednisolone acetate.
Timeline
- Start
- 2018-07-03
- Primary completion
- 2018-09-28
- Completion
- 2018-10-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Loteprednol Etabonate | Other / unclassified | 1 % | Other |
| Comparator | Prednisolone | Other / unclassified | 1 % | Other |
Indications
No indication recorded.